AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 19 filers reported holding AERPIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $79,000 | -25.5% | 46,869 | -43.1% | 0.01% | 0.0% |
| Q1 2021 | $106,000 | -36.9% | 82,306 | -51.9% | 0.01% | -55.6% |
| Q4 2020 | $168,000 | +205.5% | 171,089 | +363.1% | 0.02% | +100.0% |
| Q3 2020 | $55,000 | +139.1% | 36,946 | -0.3% | 0.01% | +350.0% |
| Q4 2019 | $23,000 | – | 37,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 5,621,835 | $7,252,000 | 3.21% |
| Parkman Healthcare Partners LLC | 1,001,189 | $1,292,000 | 0.30% |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $516,000 | 0.25% |
| Opaleye Management Inc. | 1,000,000 | $1,290,000 | 0.19% |
| EcoR1 Capital, LLC | 2,072,782 | $2,674,000 | 0.12% |
| Ikarian Capital, LLC | 2,651,093 | $3,420,000 | 0.12% |
| Scion Asset Management | 1,000,000 | $1,290,000 | 0.10% |
| Orbimed Advisors | 5,193,946 | $6,700,000 | 0.06% |
| Keudell/Morrison Wealth Management | 30,694 | $40,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 302,949 | $391,000 | 0.02% |